In 2017, a long-term collaborative project of the National Cancer Institute, the Environmental Protection Agency, and other independent health groups in the United States, known as the Agricultural Health Study, found no links between RoundUp and “any solid tumors or lymphoid malignancies overall, including non-Hogkin Lymphoma (NHL) and its subtypes.
Roundup was developed in the 1970s by the Monstanto Company, which has long defended the product against allegations of toxicity at normal levels of exposure. But in 2015, the World Health Organization’s cancer-research arm, the International Agency for Research on Cancer, or IARC, classified glyphosate-based herbicides as “probably carcinogenic to humans” based on studies conducted in animals and cell cultures.
Citing what the leader of the country’s Social Democratic party, Pamela Rendi-Wagner, called increasing “scientific evidence,” Austria’s lower house of parliament on Tuesday passed a bill banning the use of the weedkiller glyphosate, more commonly known by the brand name Roundup.
In May, a California Superior Court jury awarded an astounding $2 billion to a couple in Alameda County who claimed RoundUp caused their their non-Hodgkin’s lymphoma. (Bayer, Monsanto’s parent company, is appealing the ruling and, regardless, the final damages are likely to be significantly reduced.
In 2017, an investigation by three Bloomberg reporters found that Monsanto had paid a consulting firm that had edited drafts of a supposedly independent study that determined the herbicide was safe.